NO20083853L - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20083853L
NO20083853L NO20083853A NO20083853A NO20083853L NO 20083853 L NO20083853 L NO 20083853L NO 20083853 A NO20083853 A NO 20083853A NO 20083853 A NO20083853 A NO 20083853A NO 20083853 L NO20083853 L NO 20083853L
Authority
NO
Norway
Prior art keywords
compounds
new connections
conditions
medicament
administered
Prior art date
Application number
NO20083853A
Other languages
English (en)
Inventor
Robert Felix Galyean
Kazimierz Wisniewski
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of NO20083853L publication Critical patent/NO20083853L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelsen angår nye forbindelser, farmasøytiske sammensetninger omfattende samme, anvendelse av nevnte forbindelser for fremstillingen av et medikament for behandlingen av blant annet sjokktilstander så vel som en metode for behandling av nevnte tilstander, hvori nevnte forbindelser blir administrert. Forbindelsene er representert ved den generelle formelen (I), som ytterligere definert i beskrivelsen.
NO20083853A 2006-02-10 2008-09-08 Nye forbindelser NO20083853L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77187006P 2006-02-10 2006-02-10
PCT/US2007/003213 WO2007095021A2 (en) 2006-02-10 2007-02-05 Novel compounds

Publications (1)

Publication Number Publication Date
NO20083853L true NO20083853L (no) 2008-09-30

Family

ID=38371994

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083853A NO20083853L (no) 2006-02-10 2008-09-08 Nye forbindelser

Country Status (14)

Country Link
US (1) US8883965B2 (no)
EP (1) EP1981900B1 (no)
JP (1) JP5185830B2 (no)
KR (1) KR101194586B1 (no)
CN (1) CN101379076B (no)
AU (1) AU2007215406B2 (no)
CA (1) CA2641959C (no)
ES (1) ES2535434T3 (no)
HK (1) HK1116807A1 (no)
IL (1) IL192824A (no)
NO (1) NO20083853L (no)
NZ (1) NZ569836A (no)
RU (1) RU2415149C2 (no)
WO (1) WO2007095021A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2937B1 (en) * 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
RU2415149C2 (ru) * 2006-02-10 2011-03-27 Ферринг Б.В. Пептидные соединения
US9050286B2 (en) * 2007-08-14 2015-06-09 Ferring B.V. Use of peptidic vasopression receptor agonists
MX2011002836A (es) 2008-09-17 2011-04-28 Chiasma Inc Composiciones farmaceúticas y métodos de administración relacionados.
TWI463990B (zh) * 2009-09-21 2014-12-11 Ferring Bv 催產素受體促進劑
AU2017345720B2 (en) 2016-10-21 2023-07-27 Chiasma, Inc. Terlipressin compositions and their methods of use

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1076984A (en) 1963-04-05 1967-07-26 Sandoz Ltd Improvements in or relating to local anaesthetics containing orn-vasopressin
NL129421C (no) * 1963-08-30 1900-01-01
CS235151B1 (cs) 1982-08-26 1985-05-15 Michal Lebl Způsob dělení Dal isomerů analogů oxytocinu
US4829051A (en) * 1983-04-05 1989-05-09 Vega Laboratories, Inc. N-substituted derivatives of 1-desaminovasopressin
US4483794A (en) * 1983-05-10 1984-11-20 Ceskoslovenska Akademie Ved Analogs of neurohypophysial hormones
CS242062B1 (cs) 1984-08-23 1986-04-17 Milan Zaoral Vasopresinová a vasotocinová analoga a způsob jejich přípravy
SE457055B (sv) 1986-08-18 1988-11-28 Ferring Ab Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
SE469473B (sv) 1987-10-07 1993-07-12 Ferring Ab Vasoaktiva peptider
SE502644C2 (sv) 1990-02-27 1995-11-27 Ferring Ab Vasoaktiva vasotocinderivat
RU2063979C1 (ru) 1992-02-24 1996-07-20 Всесоюзный научно-исследовательский институт технологии кровезаменителей и гормональных препаратов Пептиды последовательности окситоцина
US5516795A (en) * 1994-09-12 1996-05-14 Abbott Laboratories Heteroatom substituted propanyl derivatives having 5-lipoxygenase inhibitory activity
GB9617021D0 (en) * 1996-08-13 1996-09-25 Salpep Biotechnology Inc Novel peptides for treatment of inflammation and shock
SE9701161D0 (sv) 1997-03-27 1997-03-27 Karolinska Innovations Ab New use I
SE9701162D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
IL138214A0 (en) 1998-03-09 2001-10-31 Zealand Pharmaceuticals As Pharmacolgically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
SE0001440D0 (sv) 2000-04-18 2000-04-18 Entretech Medical Ab A drug against climacteric disorders
WO2002064740A2 (en) 2001-02-09 2002-08-22 Cognetix, Inc. Cone snail peptides
AU2003220919A1 (en) 2002-03-29 2003-10-13 Wakamoto Pharmaceutical Co., Ltd. Drugs for increasing lacrimal fluid
US6861236B2 (en) * 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
CA2500831A1 (en) 2002-10-03 2004-04-15 Eric Hollander Treatment of autism and similar disorders
CA2557520C (en) * 2003-02-26 2011-09-13 Donald W. Landry A method for stabilizing blood pressure in hemodialysis subjects
JO2937B1 (en) * 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
RU2415149C2 (ru) 2006-02-10 2011-03-27 Ферринг Б.В. Пептидные соединения
US8222202B2 (en) * 2006-02-13 2012-07-17 Ferring B.V. Use of peptidic vasopressin receptor agonists
RU2342949C1 (ru) 2007-03-26 2009-01-10 Юрий Георгиевич Жуковский Применение [дезамино-1, изолейцин-3, аргинин-8]вазопрессина в качестве средства для увеличения выведения почкой солей натрия и усиления обратного избирательного всасывания из почечных канальцев в кровь воды-растворителя
US9050286B2 (en) * 2007-08-14 2015-06-09 Ferring B.V. Use of peptidic vasopression receptor agonists

Also Published As

Publication number Publication date
CA2641959A1 (en) 2007-08-23
WO2007095021A2 (en) 2007-08-23
ES2535434T3 (es) 2015-05-11
WO2007095021A3 (en) 2008-04-24
KR101194586B1 (ko) 2012-10-25
CN101379076B (zh) 2012-11-07
AU2007215406A1 (en) 2007-08-23
JP2009526061A (ja) 2009-07-16
CA2641959C (en) 2016-12-20
RU2008131907A (ru) 2010-03-20
US20090275522A1 (en) 2009-11-05
IL192824A0 (en) 2011-08-01
EP1981900A2 (en) 2008-10-22
JP5185830B2 (ja) 2013-04-17
CN101379076A (zh) 2009-03-04
US8883965B2 (en) 2014-11-11
EP1981900B1 (en) 2015-01-28
KR20080091802A (ko) 2008-10-14
RU2415149C2 (ru) 2011-03-27
EP1981900A4 (en) 2011-01-26
NZ569836A (en) 2010-09-30
AU2007215406B2 (en) 2011-12-08
HK1116807A1 (en) 2009-01-02
IL192824A (en) 2015-04-30

Similar Documents

Publication Publication Date Title
NO20091599L (no) Kjemiske forbindelser
NO20071314L (no) Peptidiske vasopressinreseptoragonister
WO2009155121A3 (en) Inhibitors of pi3 kinase
TW200616979A (en) Non-nucleoside reverse transcriptase inhibitors
WO2009122285A8 (en) Oxytocin analogues
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
EA201100299A1 (ru) Органические соединения
EA201190235A1 (ru) Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750
EA201270560A1 (ru) Спиропиперидиновые соединения и их фармацевтическое применение для лечения диабета
MX2011011335A (es) Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamifero de rapamicina.
CY1112429T1 (el) Υποκατεστημενα παραγωγα σουλφοναμιδιου
EA201100503A1 (ru) Глюкозидные производные и их применения
EA201100311A1 (ru) Амидные производные гетероарилов и их применение в качестве активаторов глюкокиназы
EA201201677A1 (ru) Производные гетероарилимидазолона в качестве ингибиторов jak
NO20064659L (no) Nye kvarterniserte quinuklidin-estere
EA201290416A1 (ru) Новые спиропиперидиновые соединения
EA201300250A1 (ru) Оксадиазольные ингибиторы продуцирования лейкотриена
EA201391525A1 (ru) Гликозидные производные и их применение для лечения диабета
NO20083853L (no) Nye forbindelser
MA32943B1 (fr) Piperidine spiro pyrrolidione et piperidinone substituees, leur preparation et leur utilisation therapeutique
EA201071269A1 (ru) 3,4-замещенные пиперидиновые производные в качестве ингибиторов ренина
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
WO2008098978A3 (en) Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor
NO20060718L (no) Substituerte tiofoner og deres anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application